American Society of Hematology/LinkedIn
Sep 22, 2026, 07:39
Better Trials and Better Treatments Through Greater Inclusion – American Society of Hematology
American Society of Hematology shared a post on LinkedIn about a recent article by Alan Mast and Leonard A Valentino, published in JAMA Oncology, adding:
“Better representation can lead to better trials and better treatments.
Alan Mast, MD, PhD, and Leonard A. Valentino, MD, discuss why inclusion in clinical research matters, steps ASH is taking to address barriers to participation, and tools available to help build more representative clinical trials.”
Title: Better Trials, Better Treatments: Advancing Inclusion and Representation in Clinical Trials
Authors: Alan Mast and Leonard A. Valentino
Other posts featuring American Society of Hematology on Hemostasis Today.
Alan Mast
American Society of Hematology
ASH
Clinical Research
clinical research participation
clinical trials
diversity in clinical trials
health equity
Hematologic Malignancies
Hematology
Hemostasis News
Hemostasis Today
JAMA Oncology
Leonard A. Valentino
Medical Research
Oncology
patient inclusion
representation in research
-
Sep 22, 2026, 07:18X. Long Zheng: From ADAMTS13 to New TTP Treatment
-
Sep 22, 2026, 07:11Platelet Dependent Protection Against Bacterial Pneumonia – JTH
-
Sep 22, 2026, 07:10Sumita Pandey: Apheresis Beyond Automation
-
Sep 22, 2026, 07:04Wafik El-Deiry: Type 1 interferon Alters Clonal Competition in Human Blood Development
-
Sep 22, 2026, 06:53Tania L.: Women in Hematology Take the Stage in Austin
-
Sep 22, 2026, 06:35Mahmoud Hanafy: Hayat National Hospitals Achieves AABB Accreditation
-
Sep 22, 2026, 06:01Nikola Pantic: New ASH ITP Guidelines Transform First-Line Treatment
-
Sep 22, 2026, 04:43Michael Cahillane: Highlights From BBTS2026 in Glasgow
-
Sep 22, 2026, 04:15Wolfgang Miesbach: First AAV Gene Therapy Data in Adolescents With Haemophilia B